Buscar
01/05/2026
The echo of a question, ten years later: Letter to Amanda and Jesus
Milad, C, Mesa, A. The echo of a question, ten years later: Letter to Amanda and Jesus. Endocrinologia Diabetes y Nutricion. 2026; 73(5)DOI:10.1016/j.endien.2026.501772. PMID:41887969. IF:1.800(Q3/8D).
01/05/2026
Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD)
Hong, CZ, Ballester, MP, Perricone, G, Merli, M, Buti, M, Panero, JLC, Soriano, G, Toniutto, P, Ampuero, J, Russo, FP, Sacerdoti, D, Coenraad, M, Berenguer, M, Piano, S, Sangiovanni, A, Albillos, A, Gander, A, Patel, VC, Caraceni, P, Wright, G, Iruzubieta, P, Andrade, RJ, Garcia-Samaniego, FJ, Verhelst, X, Uson, E, Sanchez-Garrido, C, Mehta, G, Jalan, R. Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease
El Maimouni, C, Jiménez-Massip, A, Canillas, L, Serra, I, Vergara, M, Morillas, RM, Poca, M, Broquetas, T, Rodríguez-Castellano, A, Munoz, EE, Soria, A, Pages, L, Carrión, J, Casas, M, Ardevol, A, Rojo, D, Alonso, N, Julián, MT, Bassegoda, O, Gines, P, Pericàs, JM, Graupera, I. Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study
Juanola, A, Moreta, MJ, Solé, C, Perez-Guasch, M, Gratacós-Ginès, J, Soria, A, Cuyàs, B, Martin-Llahi, M, Ma, A, Pompili, E, Fernández, I, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Ginès, P. Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Efficacy and safety of endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: systematic review and individual patient data meta-analysis
Biswas, S, Aggarwal, A, Lo, GH, Luo, XF, Yang, L, Escorsell, A, Mehta, S, Swaroop, S, Agarwal, S, Agarwal, A, Mishra, A, Tripathi, S, Gunjan, D, Gamangatti, S, Shalimar. Efficacy and safety of endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: systematic review and individual patient data meta-analysis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Predictive model of postoperative mortality in patients with cirrhosis. Surgical risk score for patients with cirrhosis (S-RISC)
Canillas, L, Jimenez-Esquivel, N, Amador, A, Brujats, A, Sánchez, J, Pelegrina, A, Pardo, C, Montaña, SH, Fajol, MC, de Sárraga, C, Alvarez, J, Duran, X, Burdio, F, Reverter, E, Carrión, JA. Predictive model of postoperative mortality in patients with cirrhosis. Surgical risk score for patients with cirrhosis (S-RISC). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
SIRT5 rs12216101 T > G variant is associated with hepatic encephalopathy and impaired ammonia metabolism in patients with cirrhosis
Salomone, F, Gil-Gómez, A, Barreca, F, Longo, M, Soriano, G, Francés, R, Gallego-Durán, R, Herrojo, JA, Tafani, M, Dongiovanni, P, Romero-Gómez, M. SIRT5 rs12216101 T > G variant is associated with hepatic encephalopathy and impaired ammonia metabolism in patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Rechallenge after a DILI episode: importance of the pattern and the medication class
Fernández-Aguilera, M, Calvo-Orteu, M, Aparicio, AP, Carrión, JA, de Miera, IS, Vergara, M, Poca, M, Canga, E, Ardevol, A, Ariza, X, Amador, A, Sáez-Peñataro, J, Forns, X, Barciela, MR. Rechallenge after a DILI episode: importance of the pattern and the medication class. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).